Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02666508 · ClinicalTrials.gov registry record · NA
Trial of Toothpaste to Reduce Plaque and Inflammation
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT02666508 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 61 participants.
The verdict
NCT02666508, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
Dental plaque causes caries and periodontal disease and data are sparse about toothpaste and plaque removal. Inflammation, caused by dental plaque, is a risk factor for cardiovascular disease. (CVD) The availability of (Plaque HD (TM), a plaque identifying toothpaste with targetol technology (TM)), afforded the unique opportunity to test whether there were statistically significant and clinically important reductions in plaque and inflammation in a randomized trial of apparently healthy individuals.
Interventions
- OTHER Plaque identifying toothpaste
- OTHER Non-plaque identifying toothpaste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2016-08-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02666508
The ClinicalTrials.gov registry entry for NCT02666508 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Plaque identifying toothpaste is the first listed.
NCT02666508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02666508 about?
NCT02666508 is a clinical study titled "Trial of Toothpaste to Reduce Plaque and Inflammation". Dental plaque causes caries and periodontal disease and data are sparse about toothpaste and plaque removal. Inflammation, caused by dental plaque, is a risk factor for cardiovascular disease. (CVD) The availability of (Plaque HD (TM), a plaque identifying toothpaste with targetol technology (TM)), ...
What is the current status of trial NCT02666508?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2015-09-01. Estimated completion is 2016-08-22.
What interventions are being tested in trial NCT02666508?
The interventions under investigation include: Plaque identifying toothpaste (OTHER), Non-plaque identifying toothpaste (OTHER).
Who is sponsoring clinical trial NCT02666508?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.